March 2, 2015
Enrique Conterno, President of Lilly Diabetes US drug maker Eli Lilly is poised to gain a leadership position in the Japanese diabetes arena in five years by capitalizing on its alliance with German peer Boehringer Ingelheim (BI) and a full...read more